Edition:
India

Profile: Ajanta Pharma Ltd (AJPH.BO)

AJPH.BO on Bombay Stock Exchange

1,899.00INR
3:29pm IST
Change (% chg)

Rs12.05 (+0.64%)
Prev Close
Rs1,886.95
Open
Rs1,890.00
Day's High
Rs1,901.00
Day's Low
Rs1,871.90
Volume
3,755
Avg. Vol
13,487
52-wk High
Rs2,150.00
52-wk Low
Rs1,103.00

Ajanta Pharma Limited is a holding company. The Company is a specialty pharmaceutical company engaged in developing, producing and marketing a range of branded and generic formulations. Its business includes branded generics in emerging markets of Asia and Africa, generics in the developed markets of the United States and Institutional sales. The branded generics business is spread in India and over 30 emerging countries across Africa, Commonwealth of Independent States (CIS), the Middle East and South East Asia. The Company serves a range of therapeutic segments, such as anti-biotic, anti-malarial, anti-diabetic, cardiology, gynecology, orthopedics, pediatric, respiratory and general health products. It has approximately four existing manufacturing plants located in and around Aurangabad in Maharashtra, India. The Company's subsidiaries include Ajanta Pharma (Mauritius) Ltd., Ajanta Pharma USA Inc., Ajanta Pharma Philippines Inc. and Ajanta Pharma Nigeria Ltd.

Company Address

Ajanta Pharma Ltd

Ajanta House,, Charkop, Kandivli
MUMBAI     400067
P: +9122.66061000
F: +9122.66061200

Company Web Links